Queueing Theory and COVID-19 Prevention: Model Proposal to Maximize Safety and Performance of Vaccination Sites.

COVID-19 physical distancing queueing theory safety and performance vaccination site

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 21 12 2021
accepted: 06 06 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

COVID-19 (Coronavirus Disease 19) has rapidly spread all around the world. Vaccination represents one of the most promising counter-pandemic measures. There is still little specific evidence in literature on how to safely and effectively program access and flow through specific healthcare settings to avoid overcrowding in order to prevent SARS-CoV-2 transmission. Literature regarding appointment scheduling in healthcare is vast. Unpunctuality however, especially when targeting healthcare workers during working hours, is always possible. Therefore, when determining how many subjects to book, using a linear method assuming perfect adhesion to scheduled time could lead to organizational problems. This study proposes a "Queuing theory" based approach. A COVID-19 vaccination site targeting healthcare workers based in a teaching hospital in Rome was studied to determine real-life arrival rate variability. Three simulations using Queueing theory were performed. Queueing theory application reduced subjects queueing over maximum safety requirements by 112 in a real-life based vaccination setting, by 483 in a double-sized setting and by 750 in a mass vaccination model compared with a linear approach. In the 3 settings, respectively, the percentage of station's time utilization was 98.6, 99.4 and 99.8%, while the average waiting time was 27.2, 33.84, and 33.84 min. Queueing theory has already been applied in healthcare. This study, in line with recent literature developments, proposes the adoption of a Queueing theory base approach to vaccination sites modeling, during the COVID-19 pandemic, as this tool enables to quantify ahead of time the outcome of organizational choices on both safety and performance of vaccination sites.

Identifiants

pubmed: 35874985
doi: 10.3389/fpubh.2022.840677
pmc: PMC9300952
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

840677

Informations de copyright

Copyright © 2022 Di Pumpo, Ianni, Miccoli, Di Mattia, Gualandi, Pascucci, Ricciardi, Damiani, Sommella and Laurenti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Healthc Eng. 2017;2017:6536523
pubmed: 29065634
J Med Syst. 2016 Jan;40(1):32
pubmed: 26558394
J Trauma. 1999 Jan;46(1):71-9
pubmed: 9932686
BMC Int Health Hum Rights. 2008 Nov 20;8:11
pubmed: 19021906
Anesth Analg. 1999 Oct;89(4):925-31
pubmed: 10512266
BMJ. 2020 Aug 25;370:m3223
pubmed: 32843355
Health Serv Res. 1983 Summer;18(2 Pt 1):183-208
pubmed: 6874357
Vaccines (Basel). 2021 May 14;9(5):
pubmed: 34068985
Health Care Manag Sci. 2014 Jun;17(2):101-12
pubmed: 23942762
Healthc Inform Res. 2017 Jan;23(1):35-42
pubmed: 28261529
J Emerg Trauma Shock. 2019 Oct-Dec;12(4):268-273
pubmed: 31798241
Emerg Med Clin North Am. 2020 Aug;38(3):563-572
pubmed: 32616279
Vaccine. 2008 Dec 2;26(51):6717-26
pubmed: 18955100
Inquiry. 2002-2003 Winter;39(4):400-12
pubmed: 12638714
Health Care Manag Sci. 2006 Feb;9(1):47-58
pubmed: 16613016
Glob Health Res Policy. 2020 Mar 2;5:7
pubmed: 32158961
J Med Syst. 2011 Oct;35(5):1001-14
pubmed: 20703664
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510

Auteurs

Marcello Di Pumpo (M)

Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Andrea Ianni (A)

Hospital Management, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Ginevra Azzurra Miccoli (GA)

Hospital Management, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Andrea Di Mattia (A)

Hospital Pharmacy, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Raffaella Gualandi (R)

Department of Health Professions, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Domenico Pascucci (D)

Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Walter Ricciardi (W)

Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Gianfranco Damiani (G)

Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Lorenzo Sommella (L)

Hospital Management, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Patrizia Laurenti (P)

Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH